New research partnership celebrates successful completion of first study to test new wearable devices to assess brain health and memory.
In June 2022, the Windsor Research Unit at Cambridgeshire and Peterborough NHS Foundation Trust (CPFT) partnered with the University of Cambridge Department of Clinical Neurosciences to run the Cumulus Neuroscience CNS-101 study, which aimed to assess new technology to monitor early stage dementia.
On completion of this study in March 2024, CPFT has been praised as an exemplar site by the study lead and sponsor Cumulus Neuroscience, for the hard work of the dedicated Windsor Research Unit team.
During the trial, which took place over 18 months, they screened 140 people to recruit 20 participants – 10 with early Alzheimer’s disease to compare with 10 healthy control volunteers. They ran more than 50 study visits with assessments.
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here